SET and cancer: Further, endogenous cellular inhibitors such as cancerous inhibitor of PP2A (CIP2A) and inhibitor 2 of PP2A (I2PP2A; commonly known as SET) restrains PP2A activity and are often found to be overexpressed in cancer [24, 86–89].